Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


USP8 Deubiquitinates SHANK3 to Control Synapse Density and SHANK3 Activity-Dependent Protein Levels.

Kerrisk Campbell M, Sheng M.

J Neurosci. 2018 Jun 6;38(23):5289-5301. doi: 10.1523/JNEUROSCI.3305-17.2018. Epub 2018 May 7.


A direct regulatory link between microRNA-137 and SHANK2: implications for neuropsychiatric disorders.

de Sena Cortabitarte A, Berkel S, Cristian FB, Fischer C, Rappold GA.

J Neurodev Disord. 2018 Apr 17;10(1):15. doi: 10.1186/s11689-018-9233-1.


Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling.

Buonaguro EF, Iasevoli F, Marmo F, Eramo A, Latte G, Avagliano C, Tomasetti C, de Bartolomeis A.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 2;76:29-41. doi: 10.1016/j.pnpbp.2017.02.012. Epub 2017 Feb 22.


Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects.

Zhou Y, Kaiser T, Monteiro P, Zhang X, Van der Goes MS, Wang D, Barak B, Zeng M, Li C, Lu C, Wells M, Amaya A, Nguyen S, Lewis M, Sanjana N, Zhou Y, Zhang M, Zhang F, Fu Z, Feng G.

Neuron. 2016 Jan 6;89(1):147-62. doi: 10.1016/j.neuron.2015.11.023. Epub 2015 Dec 10.


Translational neurobiology in Shank mutant mice--model systems for neuropsychiatric disorders.

Schmeisser MJ.

Ann Anat. 2015 Jul;200:115-7. doi: 10.1016/j.aanat.2015.03.006. Epub 2015 Apr 13. Review.


Shank1 regulates excitatory synaptic transmission in mouse hippocampal parvalbumin-expressing inhibitory interneurons.

Mao W, Watanabe T, Cho S, Frost JL, Truong T, Zhao X, Futai K.

Eur J Neurosci. 2015 Apr;41(8):1025-35. doi: 10.1111/ejn.12877. Epub 2015 Mar 25.


Sarm1 deficiency impairs synaptic function and leads to behavioral deficits, which can be ameliorated by an mGluR allosteric modulator.

Lin CW, Chen CY, Cheng SJ, Hu HT, Hsueh YP.

Front Cell Neurosci. 2014 Apr 1;8:87. doi: 10.3389/fncel.2014.00087. eCollection 2014.


The Potential Role of Insulin on the Shank-Postsynaptic Platform in Neurodegenerative Diseases Involving Cognition.

Chow F, Gong Y, Lippa CF.

Am J Alzheimers Dis Other Demen. 2014 Jun;29(4):303-10. doi: 10.1177/1533317513518645. Epub 2014 Jan 13. Review.


The emerging role of SHANK genes in neuropsychiatric disorders.

Guilmatre A, Huguet G, Delorme R, Bourgeron T.

Dev Neurobiol. 2014 Feb;74(2):113-22. doi: 10.1002/dneu.22128. Epub 2013 Oct 7. Review.


A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis.

Lennertz L, Wagner M, Wölwer W, Schuhmacher A, Frommann I, Berning J, Schulze-Rauschenbach S, Landsberg MW, Steinbrecher A, Alexander M, Franke PE, Pukrop R, Ruhrmann S, Bechdolf A, Gaebel W, Klosterkötter J, Häfner H, Maier W, Mössner R.

Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):117-24. doi: 10.1007/s00406-011-0233-3. Epub 2011 Sep 7.


Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons.

Critchlow HM, Maycox PR, Skepper JN, Krylova O.

Mol Cell Neurosci. 2006 Aug;32(4):356-65. Epub 2006 Jul 17.


Supplemental Content

Loading ...
Support Center